Emmennar Pharma Private Limited
U24299TG2002PTC039653ActivePrivate · Non-govt companyRoC-HyderabadUnlisted
Last updated: 2026-06-08
67
Compliance Health · C · provisional
3 / 4 signals passed
Emmennar Pharma Private Limited is a Private Non-govt company company incorporated in 2002 and based in Telangana, India. Emmennar Pharma Private Limited operates in Anti-freeze preparations, manufacturing (NIC 24299) with authorized capital of ₹20.00 Cr and paid-up capital of ₹19.87 Cr. For 2023-24, the company reported revenue of ₹394.56 Cr and profit after tax of ₹34.60 Cr. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Risk FlagsAGM 1741d ago · may be overdue
Revenue (latest FY)
₹394.56 Cr
2023-24
PAT (latest FY)
₹34.60 Cr
Margin 8.8%
Open Charges
0
No encumbrances
Active Directors
1
No resignations
Paid-up Capital
₹19.87 Cr
99% of authorized
Filings on Record
0
All current
Incorporated
2002
24 years old
State
Telangana
Sector
Anti-freeze preparations, manufacturing
NIC 24299
Class
Private
Sub-category
Non-govt company
Authorized Capital
₹20.00 Cr
Paid-up Capital
₹19.87 Cr
99% utilized
Members
—
Last AGM
24 Nov 2021
1741d ago
Last Balance Sheet
31 Mar 2021
1979d ago
Latest Filing
—
Registered Email
a*******(at)emmennar.com
Registered Office
PLOT NO: A - 4, MCH NO: 7 - 2 - A4, INDUSTRIAL ESTATE, OPP:SANATH NAGAR POLICE STATION, SANATH NAGAR HYDERABAD TG 500018 IN
Quick facts
Registered office
PLOT NO: A - 4, MCH NO: 7 - 2 - A4, INDUSTRIAL ESTATE, OPP:SANATH NAGAR POLICE STATION, SANATH NAGAR HYDERABAD TG 500018 IN
NIC code
24299
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
a*******(at)emmennar.com
Section
Anti-freeze preparations, manufacturing
ROC
RoC-Hyderabad
Website
—
Class · sub-category
Private · Non-govt company
Incorporation · Last AGM
23 Sept 2002 · 24 Nov 2021
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +20d | filed |
| MGT-7 | FY2024-25 | 21 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Emmennar Pharma Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 736577489 | Axis Bank Ltd(Bank) | ₹1.45 Cr | 04 Jul 2021 | Satisfied |
| 771422935 | HDFC Bank Ltd(Bank) | ₹3.93 Cr | 19 Sep 2020 | Open |
| 292136214 | State Bank of India(Bank) | ₹11.24 Cr | 04 Jul 2022 | Open |
| 576462503 | Kotak Mahindra Bank Ltd(Bank) | ₹8.22 Cr | 19 Sep 2021 | Satisfied |
See registered charges & lenders
Charge IDs, lenders & amounts for Emmennar Pharma Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCARevenue (bars) vs PAT (line) by FY
Revenue PAT
| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +1.0% | +12.0% | — | |
| Profit after Tax2023-24 | +90.0% | +79.0% | — | |
| Net Worth2023-24 | +43.0% | +19.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2019-20 | +11.28% | — | +18.40% | +7.56% | — | |||
| 2020-21 | +7.84% | -11.04% | +10.22% | +4.27% | — | |||
| 2021-22 | +6.03% | +27.75% | +9.12% | +3.69% | — | |||
| 2022-23 | +4.97% | +13.11% | +7.83% | +3.32% | — | |||
| 2023-24 | +8.77% | +0.56% | +12.21% | +6.38% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 1,89,62,172 | 77.80% |
| Institutional Investors | 2 | 25,02,486 | 10.27% |
| Public & Others | 15 | 29,09,451 | 11.94% |
See the full shareholding pattern
Promoter, institutional & public holding for Emmennar Pharma Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
500 peersMetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
Top quartile · P97
PAT (latest FY)
Top quartile · P98
Employees
—
—
—
—
Paid-up capital
Top quartile · P98
Compliance Health
96
96
96
Bottom quartile · P0
07
Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka) Limited
Karnataka · Inc 1981
Paid-up
Revenue
A · 96
Events & timeline
223 Sept 2015
Venkatarami appointed as Director
23 Sept 2002
Company incorporated
Emmennar Pharma Private Limited registered with RoC-Hyderabad; year 2002
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Emmennar Pharma Private Limited
When was Emmennar Pharma Private Limited incorporated?
Emmennar Pharma Private Limited was incorporated in 2002 (around 23 Sept 2002). Its CIN is U24299TG2002PTC039653 and it is registered with RoC-Hyderabad.
Where is Emmennar Pharma Private Limited located?
Emmennar Pharma Private Limited is headquartered in Telangana, at: PLOT NO: A - 4, MCH NO: 7 - 2 - A4, INDUSTRIAL ESTATE, OPP:SANATH NAGAR POLICE STATION, SANATH NAGAR HYDERABAD TG 500018 IN .
What sector does Emmennar Pharma Private Limited operate in?
Emmennar Pharma Private Limited operates in the Anti-freeze preparations, manufacturing sector (NIC code 24299), classified as Non-govt company.
Who are the directors of Emmennar Pharma Private Limited?
Emmennar Pharma Private Limited has 1 active director: Venkatarami (Director).
What is the paid-up capital of Emmennar Pharma Private Limited?
Emmennar Pharma Private Limited has authorized capital of ₹20.00 Cr and paid-up capital of ₹19.87 Cr.
Does Emmennar Pharma Private Limited have any open charges?
Emmennar Pharma Private Limited has no open MCA-registered charges on record.
What is Emmennar Pharma Private Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Emmennar Pharma Private Limited is 67/100 (grade C), based on 4 assessable weighted signals across charges, directors, capital, and overall status. 3 of 4 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.